<DOC>
	<DOCNO>NCT02757742</DOCNO>
	<brief_summary>The purpose study establish quantitative LGE mass base score system ( include LGE mass cardiac magnetic resonance , clinical feature , specific medical history , et al ) risk prediction sudden cardiac death non-ischemic dilate cardiomyopathy patient reduce leave ventricular ejection fraction</brief_summary>
	<brief_title>Quantitive LGE Mass Prediction SCD NICM Patients With Severe Cardiac Dysfunction</brief_title>
	<detailed_description>This Single-centered , Prospective , Observational Study . The study design include two phase . In Phase I , investigator enrol set consecutive patient non-ischemic cardiomyopathy perform contrast-enhanced cardiac magnetic resonance baseline severe cardiac dysfunction ( defined cardiac magnetic resonance LVEF equal less 35 % ) FuWai Hospital 2010 2013 . The investigator collect patient ' clinical baseline data cardiac magnetic resonance specific data ( Late gadolinium enhancement mass ) . All patient follow every six month phone clinical visit . The primary endpoint composite sudden cardiac death ( SCD ) , ventricular arrhythmia ( VAs ) SCD/VAs relate Implantable Cardioverter defibrillator cardiac resynchronization therapy-cardioverter defibrillator ( ICD/CRTD ) shock . The investigator plan establish quantitative LGE mass base model ( include LGE mass cardiac magnetic resonance , clinical feature , specific medical history , et al ) risk prediction sudden cardiac death analyse phase I data ( 1-year model 3-year model ) . In Phase II , investigator enroll another group non-ischemic cardiomyopathy ( NICM ) patient 2014 2015 testify risk prediction model ( 1-year model ) investigator construct phase I . The investigator aim find real high risk NICM patient may suffer SCD VAs severe cardiac dysfunction .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>Nonischemic cardiomyopathy patient receive optimal medical treatment 3 month ; Age range 10 year 65 year old； Baseline cardiac magnetic resonance LVEF≤35 % Known associate obstructive coronary Heart disease（including history myocardial infarction acute coronary event）； valvular heart disease； malignant carcinoma ； hypertensive heart disease； severe liver kidney dysfunction ； plan receive heart transplantation ； patient refuse receive cardiac magnetic resonance ； patient refuse follow ；</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>sudden cardiac death</keyword>
	<keyword>ventricular arrhythmia</keyword>
	<keyword>cardiopathy</keyword>
	<keyword>late gadolinium enhancement</keyword>
</DOC>